The commissioner of the U.S. Food and Drug Administration (FDA) drew laughter from a Washington, D.C. audience this week when she promised that the agency’s long-delayed deeming rules on e-cigarettes and other products were imminent.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.